[105]
As regards the evidentiary issues raised by Novopharm, it has to be said that the whole evidentiary record on both sides is less than satisfactory. This is primarily because Health Canada has not participated in this motion and has not provided direct evidence of what happens to documents and information that are submitted as part of the ANDS process.